3-5
2026
影响因子区间
—
平台估算
5%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:Coverage will include the following key areas: - Prospects for new and emerging therapeutics- Epidemiology of disease- Preventive strategies- All aspects of COPD, from patient self-management to systemic effects of the disease and comorbidities- Improved diagnostic methods, including imaging techniques, biomarkers and physiological tests.- Advances in the treatment of respiratory infections and drug resistance issues- Occupational and environmental factors- Progress in smoking intervention and cessation methods- Disease and treatment issues for defined populations, such as children and the elderly- Respiratory intensive and critical care- Updates on the status and advances of specific disease areas, including asthma, HIV/AIDS-related disease, cystic fibrosis, COPD and sleep-disordered breathing morbidity
【译文】涵盖以下关键领域:- 新兴治疗药物的展望- 疾病流行病学- 预防策略- 慢阻肺的所有方面,从患者自我管理到疾病的全系统效应和合并症- 改进的诊断方法,包括成像技术、生物标志物和生理测试- 呼吸道感染治疗和耐药性问题方面的进展- 职业和环境因素- 吸烟干预和戒烟方法的进展- 定义人群(如儿童和老年人)的疾病和治疗问题- 呼吸重症和危重症- 关于特定疾病领域(包括哮喘、HIV/AIDS相关疾病、囊性纤维化、慢阻肺和睡眠呼吸障碍发病率)的现状和进展更新

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |